Preventing medication errors
By David Woods (david.woods@rxcomms.com) “Since 2000, the US Food and Drug Administration (FDA) has received more than 95,000 reports of medication errors. These reports are voluntary, so the number of…
DetailsBringing healthcare to the worksite
After selling his travel company – the third largest in the US – to American Express for $6 billion, Hal Rosenbluth could have spent his time fishing, golfing, or globetrotting; instead, he co-founded Take Care Health Systems.
DetailsHow to hold on to your web visitors
By Duncan Dibble (duncan.dibble@rxcomms.com ) If you Google for ‘website’ and ‘traffic’ you’ll be inundated with miracle cures to increase visitors to your site. It will then take you roughly…
DetailsAssociation of American Medical Colleges issues task force report on industry funding of medical education
By David Woods ( david.woods@rxcomms.com ) The Association of American Medical Colleges (AAMC) recently issued a 43-page report of its task force on industry funding of medical education. Sections of…
DetailsWhy they rejected your manuscript – and what you can do about it
By David Woods (david.woods@rxcomms.com) Journal editors reject submitted manuscripts because they are: Inappropriate for their audience Poorly designed studies Poorly written Seen to have been submitted elsewhere Suspected of conflict…
DetailsIncreased calls for publishing negative clinical trial data
By Mary Gabb ( mary.gabb@rxcomms.com ) A negative result is defined as one that shows evidence of absent (or no) effect of an intervention; it is not due to absence…
DetailsIs the NHS on its last legs?
By Ruth Whittington (ruth.whittington@rxcomms.com) With the NHS in the UK nearing its 60th birthday, there’s been considerable talk about whether the system should be put into retirement. At the recent…
Details‘Big box’ companies and public health
By David Woods (david.woods@rxcomms.com) Whether it’s because of a shortage of primary care physicians, impatience at the length of time it takes to see one, or simply increasing costs, the…
DetailsThe mean versus the gene: will national healthcare systems ever adopt personalised medicine?
By John F P Bridges While outcomes for any given treatment differ significantly among patients, national healthcare systems continue to take a top down population perspective in reviewing not only…
DetailsRegulating DTC ads – Are we attempting to herd cats?
By Mary Gabb (mary.gabb@rxcomms.com) In a previous issue of HOC , we outlined some of the commonly expressed pros and cons of direct-to-consumer advertising (DTCA), which is currently allowed only…
Details